Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sumra Nazir

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Biomedicines|December 2, 2020
High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?Andrea Bonnin Márquez, Sumra Nazir, Emiel P.C. van der Vorst
Advanced Drug Delivery Reviews|October 20, 2020
Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!Sumra Nazir, Vera Jankowski, Guzide Bender, et al.
International Journal of Molecular Sciences|December 10, 2021
PCSK9 Imperceptibly Affects Chemokine Receptor Expression In Vitro and In VivoSai Sahana Sundararaman, Linsey J F Peters, Sumra Nazir, et al.
Scientific Reports|October 11, 2016
Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathyKhurrum Shahzad, Fabian Bock, Moh'd Mohanad Al-Dabet, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2016
Caspase-1, but Not Caspase-3, Promotes Diabetic NephropathyKhurrum Shahzad, Fabian Bock, Moh'd Mohanad Al-Dabet, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2017
Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic NephropathyAndi Marquardt, Moh'd Mohanad Al-Dabet, Sanchita Ghosh, et al.
Scientific Reports|May 18, 2021
Adipocyte calcium sensing receptor is not involved in visceral adipose tissue inflammation or atherosclerosis development in hyperlipidemic Apoe<sup>-/-</sup> miceSai Sahana Sundararaman, Linsey J F Peters, Yvonne Jansen, et al.
Communications Biology|October 2, 2018
Activated protein C reverses epigenetically sustained p66<sup>Shc</sup> expression in plaque-associated macrophages in diabetesKhurrum Shahzad, Ihsan Gadi, Sumra Nazir, et al.
Blood|September 9, 2017
Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibitionSumra Nazir, Ihsan Gadi, Moh'd Mohanad Al-Dabet, et al.
Circulation Research|May 9, 2025
Mitochondrial NNT Promotes Diastolic Dysfunction in Cardiometabolic HFpEFMark E Pepin, Philipp J M Konrad, Sumra Nazir, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Biomedicines|December 2, 2020
High-Density Lipoprotein Modifications: A Pathological Consequence or Cause of Disease Progression?Andrea Bonnin Márquez, Sumra Nazir, Emiel P.C. van der Vorst
Advanced Drug Delivery Reviews|October 20, 2020
Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!Sumra Nazir, Vera Jankowski, Guzide Bender, et al.
International Journal of Molecular Sciences|December 10, 2021
PCSK9 Imperceptibly Affects Chemokine Receptor Expression In Vitro and In VivoSai Sahana Sundararaman, Linsey J F Peters, Sumra Nazir, et al.
Scientific Reports|October 11, 2016
Stabilization of endogenous Nrf2 by minocycline protects against Nlrp3-inflammasome induced diabetic nephropathyKhurrum Shahzad, Fabian Bock, Moh'd Mohanad Al-Dabet, et al.
Journal of the American Society of Nephrology : JASN|February 3, 2016
Caspase-1, but Not Caspase-3, Promotes Diabetic NephropathyKhurrum Shahzad, Fabian Bock, Moh'd Mohanad Al-Dabet, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2017
Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic NephropathyAndi Marquardt, Moh'd Mohanad Al-Dabet, Sanchita Ghosh, et al.
Scientific Reports|May 18, 2021
Adipocyte calcium sensing receptor is not involved in visceral adipose tissue inflammation or atherosclerosis development in hyperlipidemic Apoe<sup>-/-</sup> miceSai Sahana Sundararaman, Linsey J F Peters, Yvonne Jansen, et al.
Communications Biology|October 2, 2018
Activated protein C reverses epigenetically sustained p66<sup>Shc</sup> expression in plaque-associated macrophages in diabetesKhurrum Shahzad, Ihsan Gadi, Sumra Nazir, et al.
Blood|September 9, 2017
Cytoprotective activated protein C averts Nlrp3 inflammasome-induced ischemia-reperfusion injury via mTORC1 inhibitionSumra Nazir, Ihsan Gadi, Moh'd Mohanad Al-Dabet, et al.
Circulation Research|May 9, 2025
Mitochondrial NNT Promotes Diastolic Dysfunction in Cardiometabolic HFpEFMark E Pepin, Philipp J M Konrad, Sumra Nazir, et al.
Pageof 2